-
INCORPORATING REAL WORLD EVIDENCE (RWE) INTO NICE TECHNOLOGY APPRAISALS: A CASE STUDY OF TA975 (TISAGENLECLEUCEL FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA)
Aug 11, 2026, 17:16 PM -
TRENDS AND BURDEN OF HEART VALVE DISEASE IN KOREA: A NATIONAL CLAIMS DATA ANALYSIS
Aug 11, 2026, 17:16 PM -
PREPARING FOR EU-LEVEL HTA OF MEDICAL DEVICES: IMPLICATIONS FOR THE FIRST JCA DEVICE ASSESSMENTS IN 2026
Aug 11, 2026, 17:16 PM -
ADDRESSING THE TIMING OF OUT-OF-POCKET MEDICINE COSTS: EARLY FINDINGS FROM A NATIONAL PILOT IN FINLAND
Aug 11, 2026, 17:16 PM -
INCREMENTAL TIGHTENING OF JAPAN'S DRUG PRICING SYSTEM: IMPLICATIONS OF THE FY2026 REFORM
Aug 11, 2026, 17:16 PM -
REAL-WORLD EFFECTIVENESS AND COST-EFFECTIVENESS OF PERTUZUMAB PLUS TRASTUZUMAB FOR HER2-POSITIVE ADVANCED BREAST CANCER IN CHINA
Aug 11, 2026, 17:16 PM -
INTEGRATING ENVIRONMENTAL SUSTAINABILITY INTO HEALTH TECHNOLOGY ASSESSMENT: A SCOPING REVIEW AND COMPARATIVE APPLICATION OF INTEGRATION METHODS USING AN INHALER CASE STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND UNCERTAINTY ANALYSIS OF ADJUVANT TRASTUZUMAB DERUXTECAN VERSUS T-DM1 IN HER2-POSITIVE EARLY BREAST CANCER: AN SSMC TERTIARY ONCOLOGY CENTER, UAE HTA PATHWAY MODEL
Aug 11, 2026, 17:16 PM -
METHODOLOGICAL CONSIDERATIONS AND RECOMMENDATIONS FOR GENERATING AND INTERPRETING QUALITATIVE PATIENT EXPERIENCE DATA ON MEANINGFUL CHANGE IN RARE PAEDIATRIC CONDITIONS
Aug 11, 2026, 17:16 PM -
DECENTRALIZED HEALTH ECONOMICS IN PRACTICE: EVIDENCE FROM STUDIES CONDUCTED BY HEALTH ECONOMICS UNITS IN BRAZIL'S UNIFIED HEALTH SYSTEM
Aug 11, 2026, 17:16 PM -
A CONFIGURATION-DRIVEN RAG EVALUATION FRAMEWORK FOR HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR)
Aug 11, 2026, 17:16 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON: ROZANOLIXIZUMAB VERSUS NIPOCALIMAB IN GENERALIZED MYASTHENIA GRAVIS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF NEWBORN SCREENING FOR SPINAL MUSCULAR ATROPHY IN CHINA
Aug 11, 2026, 17:16 PM -
STRUCTURAL BARRIERS TO PATIENT ACCESS FOR INNOVATIVE PET/SPECT RADIOTRACERS: A COMPARATIVE ANALYSIS ACROSS NINE EUROPEAN MARKETS
Aug 11, 2026, 17:16 PM -
COST-UTILITY ANALYSIS OF REMOTE ISCHEMIC CONDITIONING FOR ACUTE MODERATE ISCHEMIC STROKE BASED ON THE RICAMIS TRIAL
Aug 11, 2026, 17:16 PM -
DYNAMIC CIRCADIAN-ADJUSTED DPYD PHENOTYPING FOR FLUOROPYRIMIDINE THERAPY: AN IN SILICO COST-EFFECTIVENESS ANALYSIS FOR PRECISION ONCOLOGY
Aug 11, 2026, 17:16 PM -
VACTS: A PRAGMATIC VALUE-BASED ECONOMIC ARCHITECTURE FOR REAL-WORLD DECISION MAKING
Aug 11, 2026, 17:16 PM -
UNDERSTANDING CHILD AND PARENT PREFERENCES IN PEDIATRIC INFLAMMATORY BOWEL DISEASE MANAGEMENT
Aug 11, 2026, 17:16 PM -
UNLOCKING REAL-WORLD EVIDENCE THROUGH DATA LINKAGE: OUTCOMES OF CONTEMPORARY GLUCOSE-LOWERING THERAPIES IN OLDER ADULTS IN IRELAND
Aug 11, 2026, 17:16 PM -
ANNUAL DIRECT MEDICAL COST OF MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES IN TURKIYE: A PUBLIC PAYER MICRO-COSTING ANALYSIS
Aug 11, 2026, 17:16 PM
